PepGen Inc. Shares Sold by Frazier Life Sciences Management L.P.
PEPG Stock | USD 5.16 0.08 1.53% |
Roughly 75% of PepGen's investor base is looking to short. The analysis of the overall investor sentiment regarding PepGen suggests that many traders are alarmed. The current market sentiment, together with PepGen's historical and current headlines, can help investors time the market. In addition, many technical investors use PepGen stock news signals to limit their universe of possible portfolio assets.
PepGen |
Frazier Life Sciences Management L.P. lessened its stake in PepGen Inc. by 53.2 percent in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 702,694 shares of the companys stock after selling 800,094 shares during the quarter. Frazier Life Sciences Management
Read at thelincolnianonline.com
PepGen Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards PepGen can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
PepGen Fundamental Analysis
We analyze PepGen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PepGen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PepGen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Insiders
Shares Owned By Insiders Comparative Analysis
PepGen is currently under evaluation in shares owned by insiders category among its peers. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
PepGen Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with PepGen stock to make a market-neutral strategy. Peer analysis of PepGen could also be used in its relative valuation, which is a method of valuing PepGen by comparing valuation metrics with similar companies.
Peers
PepGen Related Equities
MOLN | Molecular Partners | 0.73 | ||||
PMVP | Pmv Pharmaceuticals | 0.64 | ||||
MNOV | MediciNova | 1.38 | ||||
ELYM | Eliem Therapeutics | 1.90 | ||||
PHVS | Pharvaris | 2.01 | ||||
CGEM | Cullinan Oncology | 2.56 | ||||
VIGL | Vigil Neuroscience | 2.67 | ||||
TYRA | Tyra Biosciences | 2.94 | ||||
ANTX | AN2 Therapeutics | 4.52 | ||||
PRTC | PureTech Health | 5.12 | ||||
EWTX | Edgewise Therapeutics | 5.54 | ||||
MLYS | Mineralys Therapeutics, | 6.02 | ||||
RLYB | Rallybio Corp | 6.67 | ||||
IPSC | Century Therapeutics | 7.41 | ||||
CCCC | C4 Therapeutics | 8.28 | ||||
TRDA | Entrada Therapeutics | 8.94 | ||||
CMPX | Compass Therapeutics | 9.58 |
Complementary Tools for PepGen Stock analysis
When running PepGen's price analysis, check to measure PepGen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PepGen is operating at the current time. Most of PepGen's value examination focuses on studying past and present price action to predict the probability of PepGen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PepGen's price. Additionally, you may evaluate how the addition of PepGen to your portfolios can decrease your overall portfolio volatility.
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |